Washington: Good news for diabetics! Thepainful shots may soon be a passe; thanks to scientists who`vedeveloped what they claim is a new form of insulin which couldbe orally inhaled for absorption via the lung. The new drug, Afrezza, which is awaiting approval fromthe US Food and Drug Administration, works faster, keeps bloodsugar levels at a closer to normal level, and has less risk ofcausing low sugar levels than the currently available insulinjabs, say the scientists.
However, experts welcomed Afrezza with caution. "They have done the required safety studies and comeout clean, but it`s only been tested for six months, so long-term isn`t known," said Sanjoy Dutta, Director of the insulininitiative at the Juvenile Diabetes Research Foundation. Dutta confirmed that Afrezza is fast-acting and lesslikely to cause low blood sugar. "Just as quickly as it has anonset of action, it also has a quick off mechanism. It doesn`tstay around long enough to cause hypoglycemia," he was quotedby the media as saying. The findings were presented recently at the AmericanChemical Society National Meeting held in California. PTI